Answer given by Mr Várhelyi on behalf of the European Commission

16.9.2025

As the Commission explained in its reply to written questions E-002611/25 and E-2696/2025 , the need to initiate a review of the approval of glyphosate in accordance with Article 21 of Regulation (EC) No 1107/2009[1] will be considered in light of the outcome of the assessment by the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA) of the study[2] published on 10 June 2025.

Following a mandate[3] from the Commission, ECHA and EFSA asked the authors of the study to provide all raw data without delay[4] and to subsequently conduct a robust and thorough scientific evaluation as to whether the new information, considered alongside all other available data, changes the agencies’ previous conclusions on glyphosate.

Until the outcome of the assessments by the agencies is completed it is not possible to provide any views on the regulatory actions or other measures to be taken by the Commission.

• [1] Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC OJ L 309, 24.11.2009, p. 1-50.
• [2] Panzacchi, S., Tibaldi, E., De Angelis, L. et al.  Carcinogenic effects of long-term exposure from prenatal life to glyphosate and glyphosate-based herbicides in Sprague-Dawley rats. Environ Health 24, 36 (2025). https://doi.org/10.1186/s12940-025-01187-2.
• [3] The mandate letter sent to the agencies can be found here: https://open.efsa.europa.eu/questions/EFSA-Q-2025-00410?search=glyphosate.
• [4] See the letter ‘ECHA-EFSA joint letter following EC mandate’ at https://open.efsa.europa.eu/questions/EFSA-Q-2025-00410?search=glyphosate.